Share

April 2021; 11 (2) Research

Neurologic Findings Among Inpatients With COVID-19 at a Safety-net US Hospital

Pria Anand, Lan Zhou, Nahid Bhadelia, Davidson H. Hamer, David M. Greer, Anna M. Cervantes-Arslanian
First published December 9, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000001031
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
3319

Share

Article Information

vol. 11 no. 2 e83-e91
DOI: 
https://doi.org/10.1212/CPJ.0000000000001031
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received August 12, 2020
  • Accepted November 2, 2020
  • First Published December 9, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Pria Anand, MD,
    2. Lan Zhou, MD (lan.zhou{at}bmc.org),
    3. Nahid Bhadelia, MD (nbhadeli{at}bu.edu),
    4. Davidson H. Hamer, MD (dhamer{at}bu.edu),
    5. David M. Greer, MD (dgreer{at}bu.edu) and
    6. Anna M. Cervantes-Arslanian, MD (anna.cervantes{at}bmc.org)
  1. Pria Anand, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Lan Zhou, MD (lan.zhou{at}bmc.org),
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH 1R01AR074428

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Nahid Bhadelia, MD (nbhadeli{at}bu.edu),
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NBC News

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIAID, Fogarty International Center

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Davidson H. Hamer, MD (dhamer{at}bu.edu),
    5. Scientific Advisory Boards:

    1. DSMB member for DMID (NIH) funded malaria sporozoite vaccine trial and BMGF iron safety study DSMB Chair for DMID (NIH) funded auranofin trial

    Gifts:

    1. Former member of WorldAware health advisory board

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate editor, American Journal of Tropical Medicine in Hygiene since 2019 Associate editor, Journal of Travel Medicine since 2018 Associate editor, Pathogens and Global Health since 2010

    Patents:

    1. NONE

    Publishing Royalties:

    1. Travel-Related Illness: The “Emerging and Unpredictable Risk” of Japanese Encephalitis - CME monograph published by Haymarket Medical Education

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant to Xenophon Strategies, Inc. and Equinox (commercial entities) Consultant to Major League Soccer and the Professional Golf Association (commercial entities)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. CDC Parasitic Diseases Branch 1 NU2GGH002322-01-00 INSECT – Implementing Novel Strategies for Education and Chagas Testing Role: co-investigator 9/30/20 – 9/29/25 2. World Health Organization Maternal, Child and Adolescent Health Department Systematic review of all aspects of childhood diarrhea 7/1/20 – 12/31/20 Role: Co-investigator 3. USAID/Zambia and Grand Challenges Canada (PI Ngoma) Subaward to Boston University (PI Scott) 3/1/2019-1/30/2022 Delivery of Community-Based Parenting Groups at Scale to Improve Early Childhood Development in Zambia (SUpErCDZ) Co-investigator 6. GeoSentinel – the global surveillance network of CDC and ISTM 5 NU50CK000478-02-00 Role: PI 9/1/16 – 8/31/21

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Bill & Melinda Gates Foundation grant INV-005691 (PI Hamer) Sequencing of Klebsiella pneumoniae isolates from Zambia 7/1/20 – 6/30/20 2. Bill & Melinda Gates Foundation grant OPP1192472 Subcontract from Hospital for Sick Children Synbiotics for the Early Prevention of Severe Infections in Infants (SEPSIS) Trial Role: Co-investigator (PI Daniel Roth) 11/7/18 – 8/31/22

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. David M. Greer, MD (dgreer{at}bu.edu) and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Becton Dickenson, Inc., travel to an international conference to give a presentation.

    Editorial Boards:

    1. Editor in chief for Seminars in Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. Book: 50 Studies Every Neurologist should Know, 2016.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Becton Dickenson, Inc., provides support to my institution for research that I'm involved with. I receive no direct compensation.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Served as a consultant in medical legal cases 2012-2020

  6. Anna M. Cervantes-Arslanian, MD (anna.cervantes{at}bmc.org)
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Boston University Medical Center (PA); and Boston University School of Medicine (LZ, NB, DHH, DMG, AMC-A), MA.
  1. Correspondence
    Dr. Anand pria2{at}bu.edu

Article usage

Article usage: December 2020 to October 2023

AbstractFullPdfSource
Dec 2020531201895Highwire
Jan 202110790309Highwire
Feb 20215010138Highwire
Mar 2021370061Highwire
Apr 2021208501157Highwire
May 2021201152121Highwire
Jun 20211531154Highwire
Jul 20211315940Highwire
Aug 2021912840Highwire
Sep 20211422837Highwire
Oct 20211515950Highwire
Nov 2021212724Highwire
Dec 20211018822Highwire
Jan 2022814614Highwire
Feb 2022168821Highwire
Mar 2022106717Highwire
Apr 2022156122Highwire
May 2022105934Highwire
Jun 20223437Highwire
Jul 20223468Highwire
Aug 202224616Highwire
Sep 202264619Highwire
Oct 202244410Highwire
Nov 202279017Highwire
Dec 202278325Highwire
Jan 202347728Highwire
Feb 2023103813Highwire
Mar 202352415Highwire
Apr 202335723Highwire
May 202313412Highwire
Jun 20231136Highwire
Jul 202343213Highwire
Aug 202321918Highwire
Sep 202371614Highwire
Oct 202353419Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles